Current Medical Imaging
Title:CT Diagnosis of Coronavirus Infection
Volume: 16
Author(s): Euishin Edmund Kim
Affiliation:
Export Options
About this article
Cite this article as:
Kim Edmund Euishin , CT Diagnosis of Coronavirus Infection, Current Medical Imaging 2020; 16 (4) . https://dx.doi.org/10.2174/157340561604200402091854
DOI https://dx.doi.org/10.2174/157340561604200402091854 |
Print ISSN 1573-4056 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6603 |
5
1
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Subject Index To Volume 12
Current Pharmaceutical Design Constrictive Pericarditis Associated with Coronavirus Disease 2019 (COVID-19): A Case Report
Infectious Disorders - Drug Targets The Role of Chloroquine and Hydroxychloroquine in Immune Regulation and Diseases
Current Pharmaceutical Design Is Ocular Toxicity Expected in Chloroquine/Hydroxychloroquine Prescription as a Therapeutic or Prophylactic Option in COVID-19?
Recent Patents on Anti-Infective Drug Discovery Recent Advances in Targeting Viral Proteases for the Discovery of Novel Antivirals
Current Topics in Medicinal Chemistry Clinical Review of COVID-19; Pathogenesis, Diagnosis, and Management
Current Pharmaceutical Design Molecular Insights into Resveratrol and Its Analogs as SARS-CoV-2 (COVID-19) Protease Inhibitors
Coronaviruses A Recent Update on Therapeutics to Treat Emerging n-COVID 19: A Review
Coronaviruses Tanta Protocol for Management of COVID-19: Perspectives from a Developing Country
Endocrine, Metabolic & Immune Disorders - Drug Targets Tocilizumab: From Rheumatic Diseases to COVID-19
Current Pharmaceutical Design Patents Review in siRNA Delivery for Pulmonary Disorders
Recent Patents on Drug Delivery & Formulation Chronic Diseases and COVID-19: A Review
Endocrine, Metabolic & Immune Disorders - Drug Targets Molecular Characterization of SARS-CoV-2
Current Molecular Medicine The Use of Cyclodextrin or its Complexes as a Potential Treatment Against the 2019 Novel Coronavirus: A Mini-Review
Current Drug Delivery How Does the Covıd-19 Pandemıc Affect the Target 90-90-90?
Current HIV Research Favipiravir in the Spotlight: In Search of Treatment Against COVID-19
Coronaviruses Exploration of (hetero)aryl Derived Thienylchalcones for Antiviral and Anticancer Activities
Medicinal Chemistry Novel Coronavirus Disease 2019 (COVID-19) Current Update: Perspective on Epidemiology, Diagnosis, Drug Targets and Vaccines
Coronaviruses Virtual Screening, Molecular Docking and <i>In silico</i> ADME-Tox Analysis for Identification of Potential Main Protease (Mpro) Enzyme Inhibitors
Anti-Infective Agents Protective Antiviral Antibodies that Lack Neutralizing Activity: Precedents and Evolution of Concepts
Current HIV Research